DIAGNOSIS OF ANOSMIA IN MIDDLE AGE INCREASES ALZHEIMER'S DEMENTIA RISK, BUT NOT IN THE ELDERLY
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Smell loss (anosmia) in middle age significantly elevates Alzheimer's dementia risk. This heightened risk is not observed in older adults, suggesting age is a critical factor in anosmia-dementia links.
Area Of Science
- Neurology
- Epidemiology
- Gerontology
Background
- Previous studies link anosmia to increased dementia incidence, primarily in older populations.
- Research on middle-aged individuals (40-65) experiencing anosmia and subsequent dementia risk is limited.
Purpose Of The Study
- To investigate the association between anosmia and the incidence of Alzheimer's and vascular dementias.
- To examine if the risk of dementia associated with anosmia differs between middle-aged and older adults.
Main Methods
- Retrospective cohort study using South Korean National Health Insurance claims data (2006-2020).
- Included 8,023 individuals diagnosed with anosmia and 2,680,534 controls, all aged 40+.
- Followed participants from 2011-2020 to track dementia diagnoses.
Main Results
- Anosmia was associated with a 15% increased incidence of Alzheimer's dementia (HR 1.15, 95% CI 1.04-1.28).
- The risk of Alzheimer's dementia was significantly higher in middle-aged anosmia patients (<65 years) compared to controls (HR 1.28, 95% CI 1.07-1.54).
- No significant increase in dementia risk was observed in older anosmia patients (≥65 years) or for vascular dementia.
Conclusions
- Anosmia diagnosed in middle age is a significant risk factor for developing Alzheimer's dementia.
- The association between anosmia and Alzheimer's dementia risk is age-dependent, being more pronounced in middle-aged individuals.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...